Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion evidence source_evidence_literature NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion SIO_000772 23734683 NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion wasDerivedFrom befree-20150227 NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_assertion wasGeneratedBy ECO_0000203 NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP883830.RAPCFiDPqI0dcdK0JgRTBgHfTi_b-AJ80p5oGMZ4MQKLI130_provenance.